Association of antidiabetic medication use, cognitive decline, and risk of cognitive impairment in older people with type 2 diabetes: Results from the population‐based Mayo Clinic Study of Aging
Abstract
To determine the cross‐sectional and longitudinal associations between diabetes treatment type and cognitive outcomes among type II diabetics.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jun 05, 2018
- Source ID
- 10.1002/gps.4900
Entities
People
- Alexandra M Wennberg
- Clinton E. Hagen
- David S. Knopman
- Kelly Edwards
- Mary M. Machulda
- Michelle M. Mielke
- Ronald C. Petersen
- Rosebud O. Roberts
Organizations
- Biogen
- Hoffmann-La Roche
- Lundbeck Foundation
- Mayo Clinic
- National Institute on Aging
- National Institutes of Health
- United States Department of Defense